We look at firms in technology, software, web, media and medical devices. All companies must be revenue generating with dramatic upside to be eligible for our periodic review sessions. We do track non-revenue generating ventures.
In addition, we run other review sessions that look at funds, large real estate deals and middle-market businesses. You can find more at IvyPlus.biz .
We have no interest in film or gaming or biotechnology projects.
We do not look at deals with long return horizons.
